The HSPA4L Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population derived from the human A-549 lung adenocarcinoma line, with targeted disruption of the HSPA4L gene. This loss-of-function model is designed for investigating HSPA4L??s role in stress-induced protein folding and apoptosis regulation. The polyclonal format comprises a heterogeneous pool of edited cells, eliminating the need for clonal isolation and providing a robust system for functional studies. It is particularly suited for research on heat shock biology, cancer cell survival, and chaperone-mediated proteostasis.
The A-549 host cell line is a human alveolar epithelial adenocarcinoma model originating from lung adenocarcinoma tissue. It is widely used in cancer research due to its epithelial characteristics and relevance to pulmonary malignancies. A-549 cells are valuable for exploring stress adaptation, as they naturally withstand proteotoxic conditions encountered in the tumor microenvironment, such as hypoxia and oxidative stress. This background makes them an ideal platform for studying HSPA4L function and the consequences of its deletion on cellular stress resilience and protein quality control.
HSPA4L encodes a stress-inducible Hsp70 family chaperone activated by HSF1 under heat shock and oxidative stress. It collaborates with Hsp40 co-chaperones and BAG family regulators to fold nascent and misfolded proteins, preventing aggregation. In apoptosis, HSPA4L interacts with BAX and caspase-3 to suppress cell death. Knockout eliminates these interactions, disrupting proteostasis and sensitizing cells to programmed death. Key pathway nodes include HSF1, HSPA4L, Bcl-2, and caspase-3, positioning the chaperone at a critical nexus of stress signaling and apoptotic control.
In A-549 cells, HSPA4L knockout compromises stress resistance, heightening vulnerability to heat shock, MG132-induced proteasome inhibition, and oxidative challenges. This sensitization is expected to reduce viability, elevate apoptosis, and lead to misfolded protein accumulation, modeling impaired protein homeostasis. The system thus allows dissection of how lung adenocarcinoma cells exploit chaperone networks for survival and may unveil therapeutic targets where HSPA4L inhibition synergizes with conventional treatments by overwhelming proteostatic capacity. It serves as a powerful tool for probing stress-induced cell death mechanisms.
Applications include heat shock response analysis via thermal challenge and western blotting for HSPA4L, apoptosis quantification through annexin V and caspase-3 assays, stress viability assays with MTT, and identification of interacting partners via co-immunoprecipitation. The cells enable pharmacological studies screening for modulators of cancer stress resilience and can be employed in protein-folding disorder research. For further information, please contact Ascent Research.
